ClinicalTrials HQ

Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations

Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations

Recruiting · NCT06772623 · Registry updated 2026-10-05
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic AlterationsNeoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasmRecruitingPhase 1 / Phase 22026-10-05NCT06772623

1 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
AbbVie340

124 results · Page 1 of 5

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Adana Medical Park Seyhan Hastanesi /ID# 272875AdanaTurkey (Türkiye)1
Aichi Cancer Center /ID# 271978NagoyaJapan1
Ankara Universitesi Tip Fakultesi Cebeci Hastanesi /ID# 272873AnkaraTurkey (Türkiye)1
Astera Cancer Care /ID# 271915East BrunswickUnited States1
AZ-Delta. /ID# 272433RoeselareBelgium1
Azienda Ospedaliera Complesso Ospedaliero San Giovanni-Addolorata /ID# 273438RomeItaly1
Azienda Ospedaliero Universitaria delle Marche /ID# 268667AnconaItaly1
Azienda Ospedaliero Universitaria San Luigi Gonzaga /ID# 268641OrbassanoItaly1
Blacktown Hospital /ID# 281588BlacktownAustralia1
Cancer Hospital - Chinese Academy of Medical Sciences /ID# 269715BeijingChina1
Centre Antoine-Lacassagne /ID# 268486NiceFrance1
Centre De Cancerologie Du Grand Montpellier /ID# 273724MontpellierFrance1
Centro Oncologico Korben /ID# 281460Buenos AiresArgentina1
Changhua Christian Hospital /ID# 280139ChanghuaTaiwan1
CHU Nantes - Hopital Laennec /ID# 268475Saint-HerblainFrance1
Clinica MedLife Polisano Sibiu /ID# 269078SibiuRomania1
Community Health Network /ID# 273437IndianapolisUnited States1
Complejo Hospitalario Universitario A Coruna /ID# 271456A CoruñaSpain1
Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation /ID# 268789Chiayi CityTaiwan1
Dana-Farber Cancer Institute /ID# 278417BostonUnited States1
First Affiliated Hospital of Shanxi Medical University /ID# 276482TaiyuanChina1
FOMAT Medical Research - Clinica mi Salud by Focil Med /ID# 274450OxnardUnited States1
Fujian Province Cancer Hospital /ID# 269150FuzhouChina1
Goztepe Prof. Dr. Suleyman Yalcin Sehir Hastanesi /ID# 280635IstanbulTurkey (Türkiye)1
Groupe Sante CHC - Clinique du MontLegia /ID# 271760LiègeBelgium1